Gene · 54
Papers2,683
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 2,683
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Can We Develop a Web-based Nomogram That Could Predict the Risk of Local Recurrence After Treatment for Giant Cell Tumor of Bone of the Extremities by Curettage? | Clin Orthop Relat Res | 2026 | 41677220 | PubTator, text mining | PubMed |
| Bone phenotype in patients with kidney failure with and without type 2 diabetes. | J Bone Miner Res | 2026 | 41603531 | PubTator, text mining | PubMed |
| CD14+ Monocytes Will Become a New Target for the Treatment of Osteoporosis: Based on Mendel Randomization, Clinical Analysis and Cell Experiment Verification. | J Cell Mol Med | 2026 | 41578166 | PubTator, text mining | PubMed |
| Bone Phenotype in Autosomal Dominant Polycystic Kidney Disease. | Calcif Tissue Int | 2026 | 41571881 | PubTator, text mining | PubMed |
| What's new on giant cell tumor of bone. | SICOT J | 2026 | 41568883 | PubTator, text mining | PubMed |
| Proposed common reference intervals for reference bone turnover markers in osteoporosis. | Pathology | 2026 | 41565485 | PubTator, text mining | PubMed |
| Profiling bone status indices reveals evidence of a low-turnover bone phenotype in type 2 diabetes: findings from the DiaFALL cohort. | Osteoporos Int | 2026 | 41563408 | PubTator, text mining | PubMed |
| Hyperbaric oxygen therapy for osteoporosis: A systematic review of preclinical evidence and mechanisms. | Bone | 2026 | 41483655 | PubTator, text mining | PubMed |
| Bone marrow lesions and serum NTx predict varus change in medial proximal tibial angle in early knee osteoarthritis. | J Orthop Sci | 2026 | 41318279 | PubTator, text mining | PubMed |
| The immune thrombocytopenia therapeutic Avatrombopag alleviates osteoporosis by targeting NFATc1 signaling. | Eur J Pharmacol | 2026 | 41297758 | PubTator, text mining | PubMed |
| Identification of TRACP 5b as a local recurrence biomarker in giant cell tumor of bone. | Surg Oncol | 2026 | 41273883 | PubTator, text mining | PubMed |
| The relationship between changes in calcium concentration and bone mineral density by anti-bone resorptive therapy. | J Clin Densitom | 2026 | 41253009 | PubTator, text mining | PubMed |
Angiotensin receptor blockers (ARBs) but not angiotensin converting enzyme inhibitors (ACE-Is) are associated with lower osteoclast activity and higher bone mineral density: Results from the TUDA study. | Bone | 2026 | 41203041 | PubTator, text mining | PubMed |
| Romosozumab's Effect on Bone Mineral Density in Patients with Osteoporosis: A Systematic Review and Meta-Analysis. | Curr Med Chem | 2026 | 40849750 | PubTator, text mining | PubMed |
| Correction: Modifying recombinant purple acid phosphatase using computational design. | Eur Biophys J | 2026 | 40782209 | PubTator, text mining | PubMed |
| Modifying recombinant purple acid phosphatase using computational design. | Eur Biophys J | 2026 | 40650743 | PubTator, text mining | PubMed |
| Intestinal gene expression in heat-stressed broilers selected for high water efficiency. | Front Physiol | 2025 | 42211328 | PubTator, text mining | PubMed |
| Effects of exercise on bone mineral density and bone turnover markers in adults: a systematic review and meta-analysis. | Front Physiol | 2025 | 41584801 | PubTator, text mining | PubMed |
| Meta-analysis of the effects of probiotic supplementation on bone turnover markers in middle-aged and elderly patients with osteoporosis. | Front Cell Infect Microbiol | 2025 | 41574289 | PubTator, text mining | PubMed |
| High prevalence and underdiagnosis of osteoporosis in total hip arthroplasty candidates: a comprehensive assessment using bone mineral density, trabecular bone score, and bone turnover markers. | J Orthop Surg Res | 2025 | 41457290 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/54/papers?page=5